Drug Profile
SP 15008
Alternative Names: SP15008Latest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Spherium Biomed
- Class Anti-inflammatories; Peptides
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in Spain
- 21 Aug 2017 Preclinical trials in Inflammatory bowel disease in Spain before August 2017 (Spherium Biomed pipeline, August 2017)